相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway
Dafeng Xu et al.
CELL DEATH & DISEASE (2021)
Proliferative polyploid cells give rise to tumors via ploidy reduction
Tomonori Matsumoto et al.
NATURE COMMUNICATIONS (2021)
Polyploidy spectrum: a new marker in HCC classification
Myriam Bou-Nader et al.
GUT (2020)
LINC00346 Acts as a Competing Endogenous RNA Regulating Development of Hepatocellular Carcinoma via Modulating CDK1/CCNB1 Axis
Jinglan Jin et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma
Ling Li et al.
CELL CYCLE (2020)
Polyploidy in liver development, homeostasis and disease
Romain Donne et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Identification and integrated analysis of hepatocellular carcinoma-related circular RNA signature
Feiran Wang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma
Bo-Han Zhang et al.
GENOMICS (2020)
Phase I safety and pharmacokinetic study of YM155, a potent selective survivin inhibitor, in combination with erlotinib in patients with EGFR TKI refractory advanced non-small cell lung cancer
Toshio Shimizu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)
MiR-490-5p inhibits the stemness of hepatocellular carcinoma cells by targeting ECT2
Yuanjie Yu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Role for polo-like kinase 4 in mediation of cytokinesis
Michael F. Press et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Analysis of potential key genes in very early hepatocellular carcinoma
Min Wu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)
The diagnostic and prognostic role of RhoA in hepatocellular carcinoma
Yi Bai et al.
AGING-US (2019)
Pseudogene RACGAP1P activates RACGAP1/Rho/ERK signalling axis as a competing endogenous RNA to promote hepatocellular carcinoma early recurrence
Meng-Yao Wang et al.
CELL DEATH & DISEASE (2019)
PLK4: a promising target for cancer therapy
Yi Zhao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
A cis-eQTL genetic variant in PLK4 confers high risk of hepatocellular carcinoma
Lijuan Meng et al.
CANCER MEDICINE (2019)
Potent Activity of Composite Cyclin Dependent Kinase Inhibition against Hepatocellular Carcinoma
Yu-Yun Shao et al.
CANCERS (2019)
CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis
Wan-Xia Yang et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Zoledronic Acid Inhibits the RhoA-mediated Amoeboid Motility o Prostate Cancer Cells
Laura Pietrovito et al.
CURRENT CANCER DRUG TARGETS (2019)
Inhibition of KIF20A by BKS0349 reduces endometriotic lesions in a xenograft mouse model
H. Ferrero et al.
MOLECULAR HUMAN REPRODUCTION (2019)
Classical and Emerging Regulatory Mechanisms of Cytokinesis in Animal Cells
Vikash Verma et al.
BIOLOGY-BASEL (2019)
Predictors of 5 year survival rate in hepatocellular carcinoma patients
Arash Sarveazad et al.
JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2019)
Chemotherapy for hepatocellular carcinoma: current status and future perspectives
Masafumi Ikeda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2018)
Survivin-targeted drug screening platform identifies a matrine derivative WM-127 as a potential therapeutics against hepatocellular carcinoma
Haisen Yin et al.
CANCER LETTERS (2018)
Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
Omar Massoud et al.
CLINICS IN LIVER DISEASE (2018)
Spatiotemporal Regulation of RhoA during Cytokinesis
Angika Basant et al.
CURRENT BIOLOGY (2018)
Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma
Mingqin Lu et al.
IUBMB LIFE (2018)
Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma
Yanlin Huang et al.
CELL DEATH & DISEASE (2018)
Reducing protein regulator of cytokinesis 1 as a prospective therapy for hepatocellular carcinoma
Xinran Liu et al.
CELL DEATH & DISEASE (2018)
PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells
Monika Raab et al.
NATURE COMMUNICATIONS (2018)
Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma
Chuan Xing Wu et al.
THERANOSTICS (2018)
A positive-feedback-based mechanism for constriction rate acceleration during cytokinesis in Caenorhabditis elegans
Renat N. Khaliullin et al.
ELIFE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
CDK1-mediated BCL9 phosphorylation inhibits clathrin to promote mitotic Wnt signalling
Jianxiang Chen et al.
EMBO JOURNAL (2018)
Plk1 overexpression induces chromosomal instability and suppresses tumor development
Guillermo de Carcer et al.
NATURE COMMUNICATIONS (2018)
Regulation and Assembly of Actomyosin Contractile Rings in Cytokinesis and Cell Repair
Corina Dekraker et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2018)
Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis
Xiao-Mei Yang et al.
GASTROENTEROLOGY (2018)
MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway
Jie Bao et al.
CELL DEATH & DISEASE (2018)
Clinical outcome and prognostic factors in hepatocellular carcinoma patients with bone metastases medicated with zoledronic acid
Yohji Honda et al.
HEPATOLOGY RESEARCH (2017)
Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma
Jianliang Chen et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2017)
PLK1, A Potential Target for Cancer Therapy
Zhixian Liu et al.
TRANSLATIONAL ONCOLOGY (2017)
Deguelin, an Aurora B Kinase Inhibitor, Exhibits Potent Anti-Tumor Effect in Human Esophageal Squamous Cell Carcinoma
Xinfang Yu et al.
EBIOMEDICINE (2017)
Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma
Jittiporn Chaisaingmongkol et al.
CANCER CELL (2017)
High-throughput screening for Survivin and Borealin interaction inhibitors in hepatocellular carcinoma
Liyun Yue et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Survivin: a unique target for tumor therapy
Himani Garg et al.
CANCER CELL INTERNATIONAL (2016)
The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway
Jianxiang Chen et al.
GUT (2016)
Bistability of a coupled Aurora B kinase-phosphatase system in cell division
Anatoly V. Zaytsev et al.
ELIFE (2016)
Inhibition of RhoA expression by adenovirus-mediated siRNA combined with TNF-α induced apoptosis of hepatocarcinoma cells
Kun Yin et al.
BIO-MEDICAL MATERIALS AND ENGINEERING (2015)
Functionality of the chromosomal passenger complex in cancer
Sanne Hindriksen et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2015)
Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma
Xiaotong Sun et al.
BMC CANCER (2015)
Discovery of MINC1, a GTPase-Activating Protein Small Molecule Inhibitor, Targeting MgcRacGAP
Arjan J. van Adrichem et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2015)
Mechanistic Insights into the Anchorage of the Contractile Ring by Anillin and Mid1
Lingfei Sun et al.
DEVELOPMENTAL CELL (2015)
The expanding implications of polyploidy
Kevin P. Schoenfelder et al.
JOURNAL OF CELL BIOLOGY (2015)
ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma
Jianxiang Chen et al.
JOURNAL OF HEPATOLOGY (2015)
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Joong-Won Park et al.
LIVER INTERNATIONAL (2015)
Bursty Gene Expression in the Intact Mammalian Liver
Keren Bahar Halpern et al.
MOLECULAR CELL (2015)
Direct interaction between centralspindlin and PRC1 reinforces mechanical resilience of the central spindle
Kian-Yong Lee et al.
NATURE COMMUNICATIONS (2015)
CDK1 structures reveal conserved and unique features of the essential cell cycle CDK
Nicholas R. Brown et al.
NATURE COMMUNICATIONS (2015)
The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma
Hongping Xia et al.
ONCOTARGET (2015)
PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis
Shiv Kumar et al.
BIOMED RESEARCH INTERNATIONAL (2015)
The Aurora B kinase in chromosome bi-orientation and spindle checkpoint signaling
Veronica Krenn et al.
FRONTIERS IN ONCOLOGY (2015)
Centrosomes and cancer: revisiting a long-standing relationship
Pierre Gonczy
NATURE REVIEWS CANCER (2015)
The chromosomal passenger complex (CPC) as a key orchestrator of orderly mitotic exit and cytokinesis
Mayumi Kitagawa et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2015)
Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
Hartmut Doehner et al.
BLOOD (2014)
Centralspindlin assembly and 2 phosphorylations on MgcRacGAP by Polo-like kinase 1 initiate Ect2 binding in early cytokinesis
Hyunjung Kim et al.
CELL CYCLE (2014)
Identification of Transcriptional and Metabolic Programs Related to Mammalian Cell Size
Teemu P. Mlettinen et al.
CURRENT BIOLOGY (2014)
The role of Aurora B expression in non-tumor liver tissues of patients with hepatocellular carcinoma
Lkhagva-Ochir Tovuu et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2014)
Silencing survivin activates autophagy as an alternative survival pathway in HCC cells
Yu-Jia Chang et al.
TUMOR BIOLOGY (2014)
Tolerance of Whole-Genome Doubling Propagates Chromosomal Instability and Accelerates Cancer Genome Evolution
Sally M. Dewhurst et al.
CANCER DISCOVERY (2014)
High Expression of Polo-Like Kinase 1 Is Associated with Early Development of Hepatocellular Carcinoma
Wei Sun et al.
INTERNATIONAL JOURNAL OF GENOMICS (2014)
miR-203 inhibits proliferation of HCC cells by targeting survivin
Wang Wei et al.
CELL BIOCHEMISTRY AND FUNCTION (2013)
Cancer cells preferentially lose small chromosomes
Pascal H. G. Duijf et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Epidemiology of Hepatocellular Carcinoma Consider the Population
Sahil Mittal et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia
F. J. Giles et al.
LEUKEMIA (2013)
In vitro contraction of cytokinetic ring depends on myosin II but not on actin dynamics
Mithilesh Mishra et al.
NATURE CELL BIOLOGY (2013)
Targeting Aurora B to the Equatorial Cortex by MKlp2 Is Required for Cytokinesis
Mayumi Kitagawa et al.
PLOS ONE (2013)
Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factors
Xun Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
KIF20A mRNA and Its Product MKlp2 Are Increased During Hepatocyte Proliferation and Hepatocarcinogenesis
Isabelle Gasnereau et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Sepantronium Bromide (YM155) induces disruption of the ILF3/p54nrb complex, which is required for survivin expression
Tomohiro Yamauchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3
Siqing Fu et al.
CANCER BIOLOGY & THERAPY (2012)
Discovery of novel inhibitors for ECT2 as a novel therapeutic strategy for lung cancer
Tracey E. Beyer et al.
CANCER RESEARCH (2012)
Tetraploid cancer cell precursors in ovarian carcinoma
Maria Castedo et al.
CELL CYCLE (2012)
The Effect of First-in-Class Small Molecule RhoA Inhibitor, HL07, on the Phenylephrine-induced Artery Contraction
Yan Zhang et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Centralspindlin links the mitotic spindle to the plasma membrane during cytokinesis
Sergey Lekomtsev et al.
NATURE (2012)
Molecular control of animal cell cytokinesis
Juan Pablo Fededa et al.
NATURE CELL BIOLOGY (2012)
The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis
Mar Carmena et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcome
Sharon I. King et al.
BREAST CANCER RESEARCH (2012)
Aurora B: A New Prognostic Marker and Therapeutic Target in Cancer
G. Portella et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Rho GTPases and their role in organizing the actin cytoskeleton
Soon-Tuck Sit et al.
JOURNAL OF CELL SCIENCE (2011)
Survivin Inhibition Is Critical for Bcl-2 Inhibitor-Induced Apoptosis in Hepatocellular Carcinoma Cells
Xiangxuan Zhao et al.
PLOS ONE (2011)
Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC
Zhong-Zhe Lin et al.
BMC CANCER (2010)
Zoledronic acid delays disease progression of bone metastases from hepatocellular carcinoma
Yoshio Katamura et al.
HEPATOLOGY RESEARCH (2010)
Active and passive tumor targeting of a novel poorly soluble cyclin dependent kinase inhibitor, JNJ-7706621
Fabienne Danhier et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Polo-like kinase 4 kinase activity limits centrosome overduplication by autoregulating its own stability
Andrew J. Holland et al.
JOURNAL OF CELL BIOLOGY (2010)
SP600125 suppresses Cdk1 and induces endoreplication directly from G2 phase, independent of JNK inhibition
J. A. Kim et al.
ONCOGENE (2010)
Plk4 is required for cytokinesis and maintenance of chromosomal stability
Carla O. Rosario et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mechanisms of contractile-ring assembly in fission yeast and beyond
Damien Laporte et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Centrosomes and cancer: how cancer cells divide with too many centrosomes
Susana A. Godinho et al.
CANCER AND METASTASIS REVIEWS (2009)
Fine Tuning the Cell Cycle: Activation of the Cdk1 Inhibitory Phosphorylation Pathway during Mitotic Exit
Tamara A. Potapova et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Kinesin superfamily motor proteins and intracellular transport
Nobutaka Hirokawa et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients
Zi-Li He et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Aurora Kinase Inhibitor PHA-739358 Suppresses Growth of Hepatocellular Carcinoma In Vitro and in a Xenograft Mouse Model
Daniel Benten et al.
NEOPLASIA (2009)
Anillin: a pivotal organizer of the cytokinetic machinery
Gilles R. X. Hickson et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocelluar carcinoma after curative hepatectomy
S. Tanaka et al.
BRITISH JOURNAL OF SURGERY (2008)
Aberrant Polo-Like Kinase 1-Cdc25A Pathway in Metastatic Hepatocellular Carcinoma
Xiao Qi Wang et al.
CLINICAL CANCER RESEARCH (2008)
Cytokinesis: Placing and making the final cut
Francis A. Barr et al.
CELL (2007)
Involvement of RhoA in progression of human hepatocellular carcinoma
Desheng Wang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Microarray analysis of gene expression of mouse hepatocytes of different ploidy
Pin Lu et al.
MAMMALIAN GENOME (2007)
Cdk1 is sufficient to drive the mammalian cell cycle
David Santamaria et al.
NATURE (2007)
Astral signals spatially bias cortical myosin recruitment to break symmetry and promote cytokinesis
Michael Werner et al.
CURRENT BIOLOGY (2007)
CCG-1423:: a small-molecule inhibitor of RhoA transcriptional signaling
Chris R. Evelyn et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinase
Andrew A. Mortlock et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma
X. R. Li et al.
EJSO (2006)
RhoA-kinase coordinates F-actin organization and myosin II activity during semaphorin-3A-induced axon retraction
Gianluca Gallo
JOURNAL OF CELL SCIENCE (2006)
Apoptosis regulation in tetraploid cancer cells
Maria Castedo et al.
EMBO JOURNAL (2006)
Phosphorylation of the cytokinesis regulator ECT2 at G2/M phase stimulates association of the mitotic kinase Plk1 and accumulation of GTP-bound RhoA
F Niiya et al.
ONCOGENE (2006)
Survivin mediates targeting of the chromosomal passenger complex to the centromere and midbody
G Vader et al.
EMBO REPORTS (2006)
Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells
T Fujiwara et al.
NATURE (2005)
Polo-like kinase 1 expression is a prognostic factor in human colon cancer
Wilko Weichert et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis
MA Ko et al.
NATURE GENETICS (2005)
Functional analysis of human microtubule-based motor proteins, the kinesins and dyneins, in mitosis/cytokinesis using RNA interference
CJ Zhu et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Regulation of myosin II during cytokinesis in higher eukaryotes
F Matsumura
TRENDS IN CELL BIOLOGY (2005)
Polyploid formation via chromosome duplication induced by CTP:phosphocholine cytidylyltransferase deficiency and bcl-2 overexpression:: Identification of two novel endogenous factors
YJ Shen et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2005)
The molecular requirements for cytokinesis
M Glotzer
SCIENCE (2005)
Updated treatment approach to hepatocellular carcinoma
JM Llovet
JOURNAL OF GASTROENTEROLOGY (2005)
From polyploidy to aneuploidy, genome instability and cancer
Z Storchova et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis
R Neef et al.
JOURNAL OF CELL BIOLOGY (2003)
Survivin promotes cell proliferation in human hepatocellular carcinoma
T Ito et al.
HEPATOLOGY (2000)
分享论文
